Dr. Charness earned his B.Sc. in Psychology from McGill University and his M.D. from the Johns Hopkins University School of Medicine. He is board certified in Internal Medicine and Neurology and current serves as a Professor of Neurology as well as the assistant dean to the VA Affairs of School of Medicine.
Dr. Charness served as Chief of Neurology at the Brockton-West-Roxbury VA and the VA Boston Healthcare System for several years. He became Chief of Staff in 2003. Additionally, Dr. Charness has served as a member of numerous advisory boards including the National Institutes of Health (NIH, served as president of the Research Society on Alcoholism (RSA), and chaired the Alcohol-Toxicology 3 Study Section. His research interests include researching alcohol’s effect on the nervous system as well as the development of drugs that block alcohol toxicity. He currently directs the NIAAA-funded Collaborative Initiative on Fetal Alcohol Spectrum Disorders and chairs the external advisory board for the NIH-funded Adolescent Brain and Cognitive Development (ABCD) study.
- Assistant Dean, VA Affairs of School of Medicine, Boston University School of Medicine
- Professor, Neurology, Boston University School of Medicine
- Johns Hopkins University, MD
- McGill University, BSc
- Published on 6/11/2020
Gupta K, Bellino PM, Charness ME. Adverse effects of nasopharyngeal swabs: Three-dimensional printed versus commercial swabs. Infect Control Hosp Epidemiol. 2020 Jun 11; 1. PMID: 32522313.
- Published on 5/1/2020
Weeks O, Bossé GD, Oderberg IM, Akle S, Houvras Y, Wrighton PJ, LaBella K, Iversen I, Tavakoli S, Adatto I, Schwartz A, Kloosterman D, Tsomides A, Charness ME, Peterson RT, Steinhauser ML, Fazeli PK, Goessling W. Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood. J Clin Invest. 2020 May 01; 130(5):2252-2269. PMID: 32202514.
- Published on 9/5/2019
Dou X, Lee JY, Charness ME. Neuroprotective Peptide NAPVSIPQ Antagonizes Ethanol Inhibition of L1 Adhesion by Promoting the Dissociation of L1 and Ankyrin-G. Biol Psychiatry. 2020 Apr 01; 87(7):656-665. PMID: 31640849.
- Published on 8/12/2019
Hagler DJ, Hatton S, Cornejo MD, Makowski C, Fair DA, Dick AS, Sutherland MT, Casey BJ, Barch DM, Harms MP, Watts R, Bjork JM, Garavan HP, Hilmer L, Pung CJ, Sicat CS, Kuperman J, Bartsch H, Xue F, Heitzeg MM, Laird AR, Trinh TT, Gonzalez R, Tapert SF, Riedel MC, Squeglia LM, Hyde LW, Rosenberg MD, Earl EA, Howlett KD, Baker FC, Soules M, Diaz J, de Leon OR, Thompson WK, Neale MC, Herting M, Sowell ER, Alvarez RP, Hawes SW, Sanchez M, Bodurka J, Breslin FJ, Morris AS, Paulus MP, Simmons WK, Polimeni JR, van der Kouwe A, Nencka AS, Gray KM, Pierpaoli C, Matochik JA, Noronha A, Aklin WM, Conway K, Glantz M, Hoffman E, Little R, Lopez M, Pariyadath V, Weiss SR, Wolff-Hughes DL, DelCarmen-Wiggins R, Feldstein Ewing SW, Miranda-Dominguez O, Nagel BJ, Perrone AJ, Sturgeon DT, Goldstone A, Pfefferbaum A, Pohl KM, Prouty D, Uban K, Bookheimer SY, Dapretto M, Galvan A, Bagot K, Giedd J, Infante MA, Jacobus J, Patrick K, Shilling PD, Desikan R, Li Y, Sugrue L, Banich MT, Friedman N, Hewitt JK, Hopfer C, Sakai J, Tanabe J, Cottler LB, Nixon SJ, Chang L, Cloak C, Ernst T, Reeves G, Kennedy DN, Heeringa S, Peltier S, Schulenberg J, Sripada C, Zucker RA, Iacono WG, Luciana M, Calabro FJ, Clark DB, Lewis DA, Luna B, Schirda C, Brima T, Foxe JJ, Freedman EG, Mruzek DW, Mason MJ, Huber R, McGlade E, Prescot A, Renshaw PF, Yurgelun-Todd DA, Allgaier NA, Dumas JA, Ivanova M, Potter A, Florsheim P, Larson C, Lisdahl K, Charness ME, Fuemmeler B, Hettema JM, Maes HH, Steinberg J, Anokhin AP, Glaser P, Heath AC, Madden PA, Baskin-Sommers A, Constable RT, Grant SJ, Dowling GJ, Brown SA, Jernigan TL, Dale AM. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. Neuroimage. 2019 11 15; 202:116091. PMID: 31415884.
- Published on 5/31/2019
Wozniak JR, Riley EP, Charness ME. Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder. Lancet Neurol. 2019 08; 18(8):760-770. PMID: 31160204.
- Published on 3/20/2018
Parnell SE, Riley EP, Warren KR, Mitchell KT, Charness ME. The contributions of Dr. Kathleen K. Sulik to fetal alcohol spectrum disorders research and prevention. Alcohol. 2018 06; 69:15-24. PMID: 29571046.
- Published on 2/6/2018
May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, Kopald D, Hasken JM, Xu R, Honerkamp-Smith G, Taras H, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, Vaux K, Jewett T, Elliott AJ, Kable JA, Akshoomoff N, Falk D, Arroyo JA, Hereld D, Riley EP, Charness ME, Coles CD, Warren KR, Jones KL, Hoyme HE. Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities. JAMA. 2018 02 06; 319(5):474-482. PMID: 29411031.
- Published on 1/3/2018
Dou X, Menkari C, Mitsuyama R, Foroud T, Wetherill L, Hammond P, Suttie M, Chen X, Chen SY, Charness ME. L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis. FASEB J. 2018 03; 32(3):1364-1374. PMID: 29109170.
- Published on 12/28/2017
Charness ME. The adolescent brain cognitive development study external advisory board. Dev Cogn Neurosci. 2018 08; 32:155-160. PMID: 29311006.
- Published on 7/27/2016
Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D, Marais AS, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, Jewett T, Coles CD, Chambers C, Jones KL, Adnams CM, Shah PE, Riley EP, Charness ME, Warren KR, May PA. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders. Pediatrics. 2016 Aug; 138(2). PMID: 27464676.
View 115 more publications: View full profile at BUMC